Search Results 1151-1160 of 18241 for Topical

  1. A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

    ... topical steroids for ongoing skin GVHD is permitted with Sponsor Medical Monitor approval. Any prior systemic anti-cancer treatment such as chemotherapy ...

  2. Dry mouth treatment: Tips for controlling dry mouth - Mayo Clinic

    To ease dry mouth, chew sugar-free gum or suck on sugar-free hard candy to keep saliva flowing. Limit caffeine and don't use tobacco. Sip water regularly.

  3. A Study Of Alternative Site Goserelin Acetate Injection For OFS In Local And Locally Advanced Premenopausal Breast Cancer - Mayo Clinic

    Receiving any estrogen or progestin containing medications, including topical estrogens. Planning to temporarily or permanently discontinue medical OFS in ...

  4. Clinical trials - Oncology (Medical)

    Dietary and Topical Magnesium Replacement or Supplementation in Patients with Lymphoma. Rochester, Minn. The purpose of this research study is to find out if ...

  5. Clinical trials - Oncology (Medical)

    Dietary and Topical Magnesium Replacement or Supplementation in Patients with Lymphoma. Rochester, Minn. The purpose of this research study is to find out if ...

  6. A Study to Evaluate the Effectiveness of Antihistamines in the Treatment of Eosinophilic Esophagitis - Mayo Clinic

    Patients who have used topical or systemic corticosteroid therapy for any reason in the previous 6 weeks. Patients who have been treated with acid ...

  7. Publications - Nahid Y. Vidal, M.D. - Mayo Clinic

    Dramatic saxophone penis as a result of topical imiquimod use. JAMA Dermatol. 2014 Dec; 150 (12):1370-1. View PubMed. PST-20492609. Home; Publications. Fuel ...

  8. A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort - Mayo Clinic

    *Allowed: Nasal, topical steroids, oral budesonide, ophthalmic. Subject must not have had a recent (within 1 week of the elevated index lab) intra-articular ...

  9. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Subject who received nonsteroidal anti-inflammatory drugs (NSAIDs) within 7 days prior to Baseline, except topical NSAIDs and low dose aspirin for ...

  10. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Use of topical (rectal) aminosalicylic acid (eg, mesalamine) or topical (rectal) steroids within 2 weeks prior to baseline; Use of intravenous or ...